Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Market Cap	198.74B
Revenue (ttm)	75.86B
Net Income (ttm)	23.50B
Shares Out	886.45M
EPS (ttm)	26.51
PE Ratio	8.46
Forward PE	8.29
Dividend	11.00 (4.88%)
Ex-Dividend Date	Nov 24, 2024

Volume	377,776
Average Volume	591,821
Open	225.60
Previous Close	225.60
Day's Range	223.50 - 225.80
52-Week Range	198.90 - 249.80
Beta	0.14
RSI	58.65
Earnings Date	Oct 23, 2025

About Paramount Global

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, anthelmintics, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxid...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 12,453
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SQURPHARMA

Financial Performance

In 2024, DSE:SQURPHARMA's revenue was 70.10 billion, an increase of 15.47% compared to the previous year's 60.71 billion. Earnings were 20.93 billion, an increase of 10.25%.